Blood Pressure Management in Stroke Following Endovascular Treatment (DETECT)
Sponsor: Hamilton Health Sciences Corporation
A PHASE2 clinical study on Blood Pressure and Endovascular Thrombectomy, this trial is completed. The trial is conducted by Hamilton Health Sciences Corporation and has accumulated 8 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Dec 2023 — Jul 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Apr 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Apr 2022 — Apr 2023 [monthly]
Recruiting PHASE2
▶ Show 3 earlier versions
-
Jan 2021 — Apr 2022 [monthly]
Recruiting PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hamilton Health Sciences Corporation
For direct contact, visit the study record on ClinicalTrials.gov .